|
Market Closed -
Bombay S.E.
03:32:26 24/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5,353.00 INR | -0.82% |
|
-0.50% | -2.76% |
| 14/08 | Alkem Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 14/08 | Alkem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Alkem Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,32,909 | 4,06,055 | 5,90,890 | 5,83,680 | 6,33,575 | 6,45,651 | - | - |
| Change | - | -6.2% | 45.52% | -1.22% | 8.55% | 1.91% | - | - |
| Enterprise Value (EV) 1 | 4,33,805 | 3,93,853 | 5,87,236 | 5,78,678 | 6,32,481 | 6,32,572 | 6,17,593 | 6,08,790 |
| Change | - | -9.21% | 49.1% | -1.46% | 9.3% | 0.01% | -2.37% | -1.43% |
| P/E | 26.3x | 41.3x | 32.9x | 27x | 27.5x | 28.1x | 24.5x | 21.1x |
| PBR | 5.01x | 4.49x | 5.73x | 4.87x | 4.58x | 4.18x | 3.69x | 3.26x |
| PEG | - | -1x | 0.4x | 1.3x | 4.37x | -96.36x | 1.6x | 1.3x |
| Capitalization / Revenue | 4.07x | 3.5x | 4.66x | 4.5x | 4.31x | 3.87x | 3.48x | 3.15x |
| EV / Revenue | 4.08x | 3.4x | 4.64x | 4.46x | 4.3x | 3.79x | 3.33x | 2.97x |
| EV / EBITDA | 21.1x | 24.5x | 26.2x | 23x | 21x | 18.5x | 15.7x | 13.7x |
| EV / EBIT | 24.8x | 30.3x | 30.2x | 26.9x | 24.1x | 21.3x | 18x | 15.6x |
| EV / FCF | 55.4x | 27.1x | 33.3x | 45.3x | 42.8x | 61.5x | 30.2x | 23.8x |
| FCF Yield | 1.81% | 3.69% | 3% | 2.21% | 2.33% | 1.63% | 3.31% | 4.19% |
| Dividend per Share 2 | 34 | 25 | 40 | 45 | 53 | 49.33 | 55.28 | 63.37 |
| Rate of return | 0.94% | 0.74% | 0.81% | 0.92% | 1% | 0.91% | 1.02% | 1.17% |
| EPS 2 | 137.6 | 82.31 | 150.2 | 181.1 | 192.5 | 191.9 | 220.7 | 256 |
| Distribution rate | 24.7% | 30.4% | 26.6% | 24.8% | 27.5% | 25.7% | 25% | 24.8% |
| Net sales 1 | 1,06,342 | 1,15,993 | 1,26,676 | 1,29,645 | 1,47,123 | 1,66,997 | 1,85,721 | 2,04,703 |
| EBITDA 1 | 20,529 | 16,094 | 22,455 | 25,122 | 30,052 | 34,213 | 39,286 | 44,365 |
| EBIT 1 | 17,490 | 12,990 | 19,462 | 21,550 | 26,232 | 29,727 | 34,232 | 39,074 |
| Net income 1 | 16,456 | 9,842 | 17,958 | 21,655 | 23,018 | 23,143 | 27,153 | 31,030 |
| Net Debt 1 | 896.1 | -12,202 | -3,654 | -5,003 | -1,094 | -13,079 | -28,058 | -36,861 |
| Reference price 2 | 3,620.70 | 3,396.10 | 4,942.00 | 4,881.70 | 5,299.00 | 5,400.00 | 5,400.00 | 5,400.00 |
| Nbr of stocks (in thousands) | 1,19,565 | 1,19,565 | 1,19,565 | 1,19,565 | 1,19,565 | 1,19,565 | - | - |
| Announcement Date | 13/05/22 | 19/05/23 | 29/05/24 | 29/05/25 | 28/05/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.74x | 12.95x | 26.26x | 0.55% | 1,11900Cr | |
| 30.06x | - | - | 1.99% | 65TCr | |
| 33.82x | 7.82x | 16.26x | 2.59% | 47TCr | |
| 20.93x | 4.96x | 12.28x | 2.66% | 37TCr | |
| 22.59x | 5.81x | 14.4x | 2.75% | 30TCr | |
| 21.46x | 4.4x | 12.56x | 2% | 26TCr | |
| 27.79x | 7.17x | 12.73x | 2.3% | 24TCr | |
| 13.71x | 4.87x | 10.23x | 3.75% | 21TCr | |
| -44.65x | 6.45x | 25.18x | 2.26% | 18TCr | |
| Average | 17.94x | 6.80x | 16.24x | 2.32% | 42.22TCr | |
| Weighted average by Cap. | 25.52x | 8.51x | 18.71x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ALKEM Stock
- ALKEM Stock
- Valuation Alkem Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
